Life sciences company Avivagen Inc (OTCMKTS:VIVXF) was in for a rude shock last Friday as its stock went through a significant selloff and ended up with a decline of as much as 7% for the day. Back in Friday the company came into focus after it announced that the annual general meeting of shareholders.
Trading Data
On Friday, VIVXF stock fell 7.33% to $0.1706 with more than 5.6K shares, compared to its average volume of 868K shares. The stock moved within a range of $0.1706 – 0.1706 after opening trading at $0.1706.
Key Update
In addition to that, Avivagen also noted that it had made considerable strides in its efforts to further expand the use of its product OxC-beta all over the world. The company announced that all the resolutions that had been put forward at the annual general meeting had been supported by the shareholders.
Some of the resolutions were related to the election of the directors at Avivagen. Another important resolution was in relation to the reappointment of the company’s auditor McGovern Hurley LLP. Kym Anthony, who is the Chief Executive Officer of the company, noted that although Avivagen had faced considerable difficulties due to the effects of the COVID 19 pandemic, things have improved considerably since the early portion of 2021. The company has been able to generate growth since then. It may now be interesting to see if the stock can actually rebound.
